Metformin and Cancer

Metformin shows promise in extending survival rates in animal models with aggressive metastatic cancer, including glioblastoma. With a remarkable increase of nearly 50% in lifespan, researchers are eager to explore the effects of combining metformin with ketogenic diets and other treatments. The innovative model developed allows for rapid testing of various interventions, shedding light on potential therapeutic strategies.